Do peptides help with obstructive sleep apnea?
2 peptides are graded for obstructive sleep apnea on this page. The strongest grade is human RCT evidence, for tirzepatide. Each one is weighed against the standard of care below, and the evidence table gives the grade and a note for every peptide.
What is the standard of care for obstructive sleep apnea?
Diagnose with a sleep study; weight loss and positional therapy where relevant; CPAP as first line for moderate to severe OSA; mandibular advancement devices for mild to moderate OSA or CPAP intolerance; hypoglossal nerve stimulation or airway surgery in selected patients; tirzepatide for moderate to severe OSA with obesity.
Any peptide below should be judged against this baseline, not against doing nothing. Talk to a licensed provider before replacing or adding to an established treatment.
Which peptides have been studied for obstructive sleep apnea?
Ordered by strength of evidence for this use. Grades follow the methodology; each peptide page lists the individual studies.
| Peptide | Evidence for this use | Note |
|---|---|---|
| Tirzepatide | Evidence: Human RCT evidence | SURMOUNT-OSA (two 52 week trials, n = 469): apnea-hypopnea index fell by 25.3 and 29.3 events per hour versus 5.3 and 5.5 on placebo, with and without PAP therapy. [2] |
| Retatrutide | Evidence: No published evidence | Its phase 3 program includes an obstructive sleep apnea study, but no OSA results have been published; not approved. [3] |
Head-to-head comparisons
Cost and access
Price ranges, lawful channels, and insurance notes for peptides graded here. State rules are in the legal guides by state.
Frequently asked questions
Which peptide has the strongest evidence for obstructive sleep apnea?
Tirzepatide has the strongest evidence among the peptides graded here, at human RCT evidence. SURMOUNT-OSA (two 52 week trials, n = 469): apnea-hypopnea index fell by 25.3 and 29.3 events per hour versus 5.3 and 5.5 on placebo, with and without PAP therapy. [2]
Is any peptide FDA approved for obstructive sleep apnea?
Tirzepatide is an FDA approved drug, but an approval covers only the indications on that label, so check the label before assuming it applies to obstructive sleep apnea. The other peptides graded here are not FDA approved. [2] [4]
Has any peptide been tested in a randomized trial for obstructive sleep apnea?
Yes, for tirzepatide. Check each note for the population and endpoints: a randomized trial in a related group or on a surrogate marker is weaker than one on the outcome you care about. [2]
From the blog
- Compounded tirzepatide in 2026: legality, cost, and safety
The tirzepatide shortage ended in December 2024 and routine compounded copies ended in 2025. What is still lawful, what it cost, FDA safety warnings, and how to check a pharmacy.
Sources
- [1]Tirzepatide for the treatment of obstructive sleep apnea and obesity. N Engl J Med 2024 (SURMOUNT-OSA)PubMed 38912654, 2024
- [2]FDA prescribing information for Zepbound (tirzepatide), via DailyMedFDA, 2025
- [3]Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials. Diabetes Obes Metab 2026PubMed 41090431, 2026
- [4]Drugs@FDA: FDA-approved drugs databaseFDA